A new approach to managing basal cell carcinomas

Those with Gorlin syndrome often develop numerous basal cell carcinomas (BCCs), starting as early as the first decade of life. As people with Gorlin syndrome know, the development of these skin cancers can cause significant
physical and emotional stress that impacts quality of life. Sol-Gel Technologies is currently evaluating a topical cream that aims to prevent the formation of new BCC lesions and reduce the need for frequent medical interventions such as surgery.

Your participation in this clinical trial could make a big impact in the prevention of skin cancers for those
with Gorlin syndrome.